jerez

VII Innovation Forum in Andalusia: Bionaturis as a successful case

Victor Infante, Bionaturis CEO, participated November 7th in the VII Innovation Forum in Andalusia, which was held at Chamber of Commerce’s facilities in Jerez (Cadiz). Bionaturis, an international reference in developing and producing biological drugs, was presented as a successful case to attendees.

Established eight years ago, Bionaturis is committed from its very beginning on innovation and thus its work in new production platforms of making biopharmaceuticals allows a more global access to them for both producers and patients. It has been listing at the Spanish MAB since January 2012 and has developed a proprietary production system –Flylife-, which allows the production of second generation vaccines using butterfly larvae.

This business forum is part of the InnoCámaras program, which seeks to foster the competitiveness of the SMEs in the region through innovation. More information of the event click here

November 4th, 2013|Blog english, congress, last news, Press english|Comments Off|

Jerez, business leadership to attract investors

Cortijo de Ducha welcomed the conference “Jerez, a city of opportunities”, gathering the cream of the financial sector of the “Jerez campiña”. Bionaturis and Carbures, represented by Javier Gallastegui and Carlos Guillén respectively, were invited as two companies successfully implemented in the city, being notorial examples of innovative business model.
In this way, the City of Jerez is positioned as an attractive business environment for entrepreneur activity in the province and elsewhere. A total of 180 attendees were invited to share best practices and experiences to successful entrepreneurship, including joint initiatives between companies.
Sectors as Agro-industrial, Tourism and Technological Innovation were in the spotlight during the conference. Among other speakers, the former sector was represented by Bionaturis, established as a spin-off of the University of Cadiz in 2005, and trading at the Spanish MAB for SMEs seven years later (ticker BNT),. Since then, and thanks to intensive innovation, the company pursues its vision of a “Global access to health”. “Our proprietary FLYLIFE system makes our manufacturing facilities in Jerez de la Frontera reach one of the highest producing capacities of biological drugs in Spain”, stated Javier Gallastegui, manager director of the company.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR